Information about the shortage of the medicinal product Xyzal 0.5 mg/ml oral solution (levocetirizine)
Medis Adria d.o.o., the marketing authorisation holder for the medicinal product Xyzal 0.5 mg/ml oral solution (levocetirizine), has informed the Agency for Medicinal Products and Medical Devices about the expected shortage of this product on the Croatian market. The shortage is due to a manufacturing delay.
The normalisation of the supply chain with the product is expected by the end of April 2013. Other medicinal products from the same therapeutic group are available on the Croatian market.